GHRP-6 (Growth Hormone Releasing Peptide-6) Primary uses: Muscle growth Growth hormone release Appetite stimulation Injury healing Typical dosing: 100-300mcg, 2-3 times daily Best on empty stomach Duration: 3-6 months Administration: Subcutaneous injection Special notes: Strong appetite increase (pro or con depending on goals) Powerful GH release Can increase prolactin (monitor for gynecomastia) Older peptide, still effective GHRP-2 Primary uses: Growth hormone release Muscle growth Fat loss Typical dosing: 100-300mcg, 2-3 times daily Duration: 3-6 months Administration: Subcutaneous injection Special notes: Similar to GHRP-6 but less hunger Still some prolactin increase Good middle-ground between GHRP-6 and Ipamorelin IGF-1 LR3 (Insulin-like Growth Factor) Primary uses: Muscle growth (most anabolic peptide) Muscle recovery Body recomposition Nutrient partitioning Typical dosing: 40-80mcg daily 4-6 week cycles Duration: Cycles with breaks (not continuous) Administration: Subcutaneous or intramuscular injection Special notes: Very powerful for muscle growth Requires cycling (not for long-term use) Risk of hypoglycemia (carry fast carbs) Advanced peptide (not for beginners) Hexarelin Primary uses: Powerful GH release Muscle growth Appetite stimulation Typical dosing: 100-200mcg, 2-3 times daily Duration: 4-8 weeks, then break (desensitization occurs) Administration: Subcutaneous injection Special notes: Most powerful GHRP Significant hunger increase Desensitization with continuous use (need breaks) Increases prolactin and cortisol more than other GHRPs Learn complete muscle protocols in our best peptides for muscle growth guide

BPC-157 upregulates vascular endothelial growth factor (VEGF) receptors and activates endothelial nitric oxide synthase (eNOS), both critical for blood vessel formation and endothelial repair
What's the response time for urgent issues
the honest EFSA 2011 non-substantiation and the excellent safety record (GRAS status, no serious effects to 900 mg/day) versus Dihexas unproven HGF/c-Met synaptogenesis, the fosgonimeton LIFT-AD failure and the pro-proliferative c-Met concern, and why the cheap, safe, legal tea amino acid wins comprehensively
[2] Second, in cultured dermal microvascular and fibroblast models, GHK-Cu exposure has been associated with increased vascular endothelial growth factor expression, a change that could enhance perifollicular microcirculation